HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ocrelizumab

an anti-CD20 antibody for treatment of autoimmune disease and cancer
Also Known As:
PR 070769; PR-070769; PR070769; R 1594; R-1594; R1594
Networked: 19 relevant articles (5 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hauser, Stephen L: 2 articles (07/2014 - 11/2011)
2. Leppert, David: 2 articles (07/2014 - 11/2011)
3. Olech, Ewa: 2 articles (01/2014 - 08/2012)
4. Dummer, Wolfgang: 2 articles (08/2012 - 09/2008)
5. Travers, H: 2 articles (02/2012 - 02/2012)
6. Dummer, W: 2 articles (02/2012 - 02/2012)
7. Moral, M A: 2 articles (11/2010 - 06/2008)
8. Tomillero, A: 2 articles (11/2010 - 06/2008)
9. Sweiss, Nadera J: 2 articles (07/2009 - 09/2008)
10. Ontaneda, Daniel: 1 article (06/2015)

Related Diseases

1. Rheumatoid Arthritis
2. Lupus Nephritis
3. Multiple Sclerosis
4. Infection
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Methotrexate (Mexate)
2. rituximab (Mabthera)
3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4. leflunomide (Arava)
5. Simvastatin (Zocor)
6. alemtuzumab (Campath)
7. Neutralizing Antibodies
8. Interferon-beta
9. Mitoxantrone (Novantrone)
10. Glucocorticoids

Related Therapies and Procedures

1. Intravenous Infusions
2. Stents